Zusammenfassung
Im Hinblick auf die Anwendung kontrazeptiver Methoden ist es in der Zeit von 1970 bis 1980 zu deutlichen Veränderungen gekommen. Die hormonale Kontrazeption hat einen weiteren Aufschwung erfahren. Während noch 1970 etwa 30 Millionen Frauen die Pille zur Kontrazeption anwendeten, sind es zur Zeit 60–80 Millionen; insgesamt haben 150 Millionen Frauen bereits Erfahrung mit der hormonalen Kontrazeption. In den lateinamerikanischen Ländern sind mechanische Hilfen bei der Frau (Scheidendiaphragma) sowie Verhaltensmethoden mehr in den Vordergrund getreten. Das Intrauterinpessar konnte sich weltweit nur allmählich durchsetzen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Beral V, Ramcharan S, Fans R (1977): Malignant melanoma and oral contraceptive use among women in California. Brit J Cancer 36: 804–809
Eser A, Hirsch HA (Hrsg.) (1980): Sterilisation und Schwangerschaftsabbruch. Enke Verlag, Stuttgart
Jordan WM (1961): Pulmonary embolism. Lancet II 1146–1147
Grabowski MU, Stenram U, Bergqvist A (1975): Focal nodular hyperplasia of the liver, benign hepatomas, oral contraceptives and other drugs affecting the liver. Acta path microbiol scand Section A 83 615–622
Hoover R, Bain C, Cole P, MacMahon B (1978): Oral contraceptive use: association with frequency of hospitalization and chronic disease risk indicators. Am J Public Health 68: 355–361
Mishell DR (1979): Oral Steroids, in: Reproductive Endocrinology, Infertility and Contraception, Davis Company, Philadelphia
Morrison AS, Jick H, Ory HW (1977): Oral contraceptives and hepatitis. A report from the Boston Surveillance Program, Boston University Medical Center. Lancet I 1142–1143
Petitti DB, Wingerd J, Pelegrin F, Ramcharan S (1978): Oral contraceptives, smoking and other factors in relation to the risk of venous thromboembolic disease. Am J Epedem 108: 480–485
Population Reports (1982): Oral Contraceptives: Oral contraceptives in the 1980s. Series A, Number 6, May-June. Population Information Program, The Johns Hopkins University, Baltimore, Maryland, USA.
Rabe T, Runnebaum B (1982): Kontrazeption. Springer-Verlag, Berlin-Heidelberg-New York
Ramcharan S, Pellegrin FA, Ray R, Hsu JP (1981): General description of the study; characteristics of the cohort; followup of the cohort. In: Ramcharan S, Pellegrin FA, Ray R and Hsu JP, The Walnut Creek Contraceptive Drug Study: a prospective study of the side effects of oral contraceptives. Vol. 3. An interim report - a comparison of disease occurence leading to hospitalization or death of users and nonusers of oral contraceptives. Bethesda, Maryland, Center for Population Research, p. 1–26
Royal College of General Practitioners (1974): Oral contraception and health; an interim report from the oral contraception study of the Royal College of General Practitioners. Pitman New York
Royal College of General Practitioners (1978): Oral Contraceptive Study: Oral Contraceptives, venous thrombosis and varicose veins. Journal of the Royal College of General Practitioners 28: 393–399
Royal College of General Practitioners’ Oral Contraceptive Study (1977): Mortality among oral contraceptive users. Lancet II 727–731
Royal College of General Practitioners Oral Contraceptive Study (1981): Further analyses of mortality in oral contraceptive users. Lancet 541–546
Runnebaum B, Rabe T (1982): Risiko-Nutzen-Analyse der hormonalen Kontrazeption. Deutsches Ärzteblatt 79: 29–48
Shapiro S, Slone D, Rosenberg L, Kaufman DW, Stolley PD, Miettinen OS (1979): Oral-contraceptive use in relation to myocardial infarction. Lancet I 743–747
Slone D, Shapiro S, Kaufman DW, Rosenberg L, Miettinen OS, Stolley PD (1981): Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. New England J Med 305:420–424
Sturtevant FM (1979): Oral contraceptives and liver tumors, in: Controversies in Contraception. KS Moghissi (Hrsg.), The Williams & Wilkins Company, Baltimore 93–150
Tietze CH, Lewit S (1977/1978): Mortality and Fertility Control. Int J Gynaecol Obstet 15: 100 and 16:456–459
Vessey M, Doll R, Johnson B, Wiggins P (1976): A long-term follow-up study of women using different methods of contraception - an interim report. J Biosoc Sci 8: 375–427
Vessey MP, McPherson K, Johnson B (1977): Moratility among women participating in the Oxford/Family Planning Association contraceptive study. Lancet II 731–733
Vessey MP, Kay CR, Baldwin JA, Clarke B, MacLeod IB (1977): Oral contraceptives and benign liver tumours. Brit Med J II 1064
Wingrave SJ (1982): Progestogen effects and their relationship to lipoprotein Changes. Acta Obstet Gynecol Scand Suppl. 105: 33–36
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt
About this paper
Cite this paper
Runnebaum, B., Rabe, T. (1985). Risikoanalyse der hormonalen Kontrazeption. In: Runnebaum, B., Rabe, T. (eds) Hormonale Kontrazeption. Steinkopff. https://doi.org/10.1007/978-3-642-85340-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-85340-1_1
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-0646-6
Online ISBN: 978-3-642-85340-1
eBook Packages: Springer Book Archive